Sterling Investment Advisors (Pennsylvania)’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-81
Closed -$14K 460
2020
Q1
$14K Hold
81
0.01% 298
2019
Q4
$15K Hold
81
0.01% 322
2019
Q3
$14K Hold
81
0.01% 323
2019
Q2
$14K Hold
81
0.01% 331
2019
Q1
$12K Hold
81
0.01% 331
2018
Q4
$10K Sell
81
-110
-58% -$13.6K 0.01% 332
2018
Q3
$36K Hold
191
0.02% 259
2018
Q2
$31K Hold
191
0.02% 254
2018
Q1
$32K Sell
191
-110
-37% -$18.4K 0.02% 251
2017
Q4
$49K Hold
301
0.03% 191
2017
Q3
$62K Sell
301
-92
-23% -$18.9K 0.04% 164
2017
Q2
$96K Hold
393
0.06% 138
2017
Q1
$94K Hold
393
0.07% 133
2016
Q4
$83K Buy
+393
New +$83K 0.07% 130

Sterling Investment Advisors (Pennsylvania)'s AGN Position: Q2 2020 in Review

Sterling Investment Advisors (Pennsylvania) sold out of Allergan Inc (AGN) in Q2 2020, closing a stake of 81 shares — an estimated $14K sold.

Sterling Investment Advisors (Pennsylvania) first reported a position in AGN in Q4 2016 and held it in 14 quarters. The position peaked at $96K in Q2 2017. 0 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Sterling Investment Advisors (Pennsylvania) reported no remaining Allergan Inc position as of Q2 2020 after selling out during the quarter.
  • Sterling Investment Advisors (Pennsylvania) sold 81 Allergan Inc shares in Q2 2020, an estimated $14K.
  • Sterling Investment Advisors (Pennsylvania) first reported a position in Allergan Inc in Q4 2016 and held it in 14 quarters.
  • Sterling Investment Advisors (Pennsylvania)'s Allergan Inc position peaked at $96K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2020.

Based on Sterling Investment Advisors (Pennsylvania)'s 13F filing for Q2 2020, filed 24 Jul 2020.